Jiangxi Synergy Pharmaceutical Co., Ltd. (SHE:300636)
7.82
+0.05 (0.64%)
Apr 30, 2026, 3:04 PM CST
SHE:300636 Revenue
In the year 2025, Jiangxi Synergy Pharmaceutical had annual revenue of 828.66M CNY with 9.19% growth. Jiangxi Synergy Pharmaceutical had revenue of 192.42M in the quarter ending December 31, 2025, with 1.83% growth.
Revenue
828.66M
Revenue Growth
+9.19%
P/S Ratio
3.96
Revenue / Employee
584.39K
Employees
1,418
Market Cap
3.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 828.66M | 69.77M | 9.19% |
| Dec 31, 2024 | 758.89M | 36.75M | 5.09% |
| Dec 31, 2023 | 722.14M | 2.23M | 0.31% |
| Jan 1, 2023 | 719.91M | 127.78M | 21.58% |
| Dec 31, 2021 | 592.13M | 156.71M | 35.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guizhou Yibai Pharmaceutical | 1.72B |
| Shaanxi Panlong Pharmaceutical Group Limited By Share | 1.11B |
| Hunan Hansen Pharmaceutical | 1.05B |
| Anhui Sunhere Pharmaceutical Excipients | 956.32M |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.26M |
| Zhejiang Shengda Bio-Pharm | 830.53M |
| Baotou Dongbao Bio-Tech Co.,Ltd | 747.80M |
| Honz Pharmaceutical | 466.12M |